Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: ivan solotaroff who wrote (729)	1/8/1998 3:39:00 PM
From: Naggrachi	Read Replies (1) \| Respond to of 2068

<<Why is this still positive news for OXFD?>> Why you ask? Will if Michael Price (MP) is forcing management changes in Pacificare, What do you think that signals to OXHP's managment, if MP did purchase a stake in the company? As to your short postion, it's no different that buying OXHP in the 80's and going long on the company. Good luck. :-) Zead

To: ivan solotaroff who wrote (729)	1/8/1998 5:57:00 PM
From: Premier	Read Replies (1) \| Respond to of 2068

Ivan: If Pacificare gets Price's endorsement and his call is correct, it should move higher. Oxford, being an industry particiapant, should generally move in the direction of Pacificare. Appointment of new executive committee consisting of turn around experts and search for new CEO (while retaining current CEO) signals management's resolve to improve shareholder value. In the short run you have gain on your short. In the long run longs have better odds at Oxford. IMHO, the talks of Oxford's death are premature. Premier